I help procurement, category management and commercial teams make faster sourcing decisions — building market sizing models, supplier landscapes, cost benchmarks and scopes of work across clinical, patient-services and consumer-health categories.
Six recurring workstreams across the engagements in my research library.
TAM/SAM/SOM builds, regional splits and CAGR forecasts using primary + secondary triangulation.
Long-list to short-list supplier mapping with operational, geographic and functional capability scoring.
Porter's Five Forces, SWOT and negotiation-leverage assessments built for category strategy decks.
Cost-structure breakdowns and category-specific savings levers with implementation risk flags.
Procurement-ready SOWs — objectives, actionables, timelines and project teams — for sourcing engagements.
Independent research on emerging consumer-health categories, from demographics to channel economics.
Interactive Power BI dashboards and visual analytics that turn complex market and business data into actionable insights.
10 category intelligence reports from my research library. Ask for a full sample deck on any category below.
Mapped the HUB-support landscape — single-point-of-contact services connecting rare-disease and high-cost-therapy patients to manufacturers, physicians and payers — covering demand drivers, negotiation leverage and supplier shortlisting.
Two linked studies on financial-assistance categories — patient assistance programs and copay-card services — benchmarking supplier models, accumulator/maximizer policy shifts and enrollment-technology trends shaping vendor selection.
Evaluated the adherence-technology supplier space — smart packaging, reminder platforms and counselling services — with a competitive landscape review and a case study on a leading adherence-program vendor.
Sized the North American specialty-infusion market and benchmarked a 45+ supplier landscape spanning CROs and niche infusion specialists, with recommendations tied to home-based and outpatient care growth.
Assessed comparator-sourcing channels and Expanded Access Program (EAP) capability tiers under the 21st Century Cures Act, segmenting the supplier base into full-service, mid-tier and logistics-only specialists.
Applied a structured Define–Size–Benchmark framework to the global lab supplies/equipment category, including supplier M&A tracking, a best-practice matrix and a Porter's Five Forces read on buyer leverage.
Authored formal SOWs translating procurement objectives into optimization parameters, business questions and actionables — covering market analysis, supplier identification/capability mapping, timelines and project governance.
Identified savings levers across lab asset management (supply-base consolidation, lifecycle management, procurement optimization) and patient recruitment & retention (digital recruitment, decentralized trials, wearables), each scored for savings potential and implementation risk.
Two self-initiated studies on the medical and cosmetic pedicure/podiatry space — cost structures, clientele demographics, salon density by state and awareness of podiatric foot care.
Built structured supplier-selection workbooks — research methodology, selection criteria and long-lists — for specialty diagnostics and home-healthcare-nursing categories, scored on operational, geographic and functional fit.
The same five-step framework runs under every engagement above.
Scope, sub-services and buyer decision factors.
TAM/SAM/SOM, regional split, forecast horizon.
Cost structure, drivers/constraints, SWOT, Porter's.
Long-list → capability scoring → short-list.
Negotiation leverage, sourcing strategy, next steps.
A lean, senior-led practice — no junior pass-through, no templated output.
I am an independent market research consultant specializing in the pharmaceutical, biotech, and healthcare sectors. I partner with organizations — from global pharmaceutical companies and medical device manufacturers to private equity funds and specialist consultancies — to deliver rigorous, decision-ready market intelligence.
My research combines primary fieldwork — executive interviews, expert panels, payer surveys — with deep secondary analysis of regulatory databases, clinical registries, company filings, and reimbursement policy sources. Every study is built to answer a specific strategic question, not to produce a generic market report.
Unice Research operates as a lean, senior-led practice: no junior pass-through, no templated output. Every client works directly with me from scoping through delivery.
Whether you have a well-defined research brief or an early-stage strategic question, I'm happy to discuss scope, timelines and budget. Initial consultations are always complimentary.